Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB25FN3SE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,594
Award facts
- Contract value 100% obligated
- $1,594.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xolair 300 mg/2 ml auto-injector units, with a contract value of $1,594.16 and an ultimate completion date of August 29, 2025. This non-set-aside, competitively awarded delivery order operates under firm fixed pricing and is being performed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The SPE2DX prime contract functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for Xolair, a specialty pharmaceutical product, exemplifies the company's ongoing role in fulfilling medical supply requirements for the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FN3SE?
SPE2DB25FN3SE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FN3SE worth?
The government has obligated $1,594 on SPE2DB25FN3SE.
Is contract SPE2DB25FN3SE an order under another contract?
Yes. SPE2DB25FN3SE is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN3SE competed?
The extent of competition for SPE2DB25FN3SE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award